
BioSig Technologies, Inc.
- Jurisdiction
United States - ISIN
US09073N3008 (BSGM )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. Read full profile
Stock price
Fundamentals
- Net revenue
€11.15K - Gross margin
-1,184.6% - EBIT
-€23.58M - EBIT margin
-211,400.0% - Net income
-€22.48M - Net margin
-201,515.4%
Statement period: - (published )
Dividends
No dividend payouts